Can-Fite BioPharma Statistics

Total Valuation

CANF has a market cap or net worth of $15.46 million. The enterprise value is $10.70 million.

Market Cap	15.46M
Enterprise Value	10.70M

Important Dates

The next estimated earnings date is Tuesday, April 8, 2025, before market open.

Earnings Date	Apr 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CANF has 1.67 billion shares outstanding. The number of shares has increased by 57.39% in one year.

Current Share Class	n/a
Shares Outstanding	1.67B
Shares Change (YoY)	+57.39%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.01B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.17
Forward PS	13.61
PB Ratio	6.24
P/TBV Ratio	6.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	16.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.02.

Current Ratio	2.93
Quick Ratio	2.38
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -157.62% and return on invested capital (ROIC) is -102.80%.

Return on Equity (ROE)	-157.62%
Return on Assets (ROA)	-57.46%
Return on Invested Capital (ROIC)	-102.80%
Return on Capital Employed (ROCE)	-198.04%
Revenue Per Employee	$83,375
Profits Per Employee	-$921,375
Employee Count	8
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.51% in the last 52 weeks. The beta is 0.26, so CANF's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-34.51%
50-Day Moving Average	1.59
200-Day Moving Average	2.17
Relative Strength Index (RSI)	43.57
Average Volume (20 Days)	356,082

Short Selling Information

Short Interest	204,385
Short Previous Month	177,658
Short % of Shares Out	3.76%
Short % of Float	n/a
Short Ratio (days to cover)	1.95

Income Statement

In the last 12 months, CANF had revenue of $667,000 and -$7.37 million in losses. Loss per share was -$0.00.

Revenue	667,000
Gross Profit	667,000
Operating Income	-7.79M
Pretax Income	-7.63M
Net Income	-7.37M
EBITDA	-7.79M
EBIT	-7.79M
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

The company has $4.73 million in cash and $57,000 in debt, giving a net cash position of $4.67 million or $0.00 per share.

Cash & Cash Equivalents	4.73M
Total Debt	57,000
Net Cash	4.67M
Net Cash Per Share	$0.00
Equity (Book Value)	2.48M
Book Value Per Share	0.00
Working Capital	3.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.43 million and capital expenditures -$4,000, giving a free cash flow of -$7.44 million.

Operating Cash Flow	-7.43M
Capital Expenditures	-4,000
Free Cash Flow	-7.44M
FCF Per Share	-$0.00

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,168.37%
Pretax Margin	-1,105.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CANF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.39%
Shareholder Yield	n/a
Earnings Yield	-47.69%
FCF Yield	-48.10%

Dividend Details

Analyst Forecast

The average price target for CANF is $14.00, which is 845.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	845.95%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 9, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

CANF has an Altman Z-Score of -40.01 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-40.01
Piotroski F-Score	1